We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp

Delisted

NVIV was delisted on the 12th of February, 2024.

37 hedge funds and large institutions have $43.9M invested in InVivo Therapeutics Holdings Corp in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

438% more call options, than puts

Call options by funds: $4.73M | Put options by funds: $879K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more funds holding

Funds holding: 3537 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

34% less capital invested

Capital invested by funds: $66.6M → $43.9M (-$22.7M)

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
10
Reduced
1
Closed
4
Calls
$4.73M
Puts
$879K
Net Calls
+$3.85M
Net Calls Change
+$4.41M

NVIV Hedge Fund Activity: Q3 2015 in Review

37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q3 2015, worth a combined $43.9M — down 34% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVIV positions and 4 closed out — a net gain of 2 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $3.04M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.01M sold.

  • 37 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q3 2015, up from 35 in Q2 2015.
  • Funds reported $43.9M of InVivo Therapeutics Holdings Corp stock for Q3 2015, down 34% quarter-over-quarter.
  • 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q3 2015 and 4 closed out, a net change of +2 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $3.04M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q3 2015 was Bogle Investment Management, an estimated $4.01M sold.

Based on aggregated 13F filings for Q3 2015.